Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Martin Lauss; Marco Donia; Katja Harbst; Rikke Andersen; Shamik Mitra; Frida Rosengren; Maryem Salim; Johan Vallon-Christersson; Therese Törngren; Anders Kvist; Markus Ringnér; Inge Marie Svane; Göran Jönsson

doi:10.1038/s41467-020-15531-2

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Martin Lauss, Marco Donia, Katja Harbst, Rikke Andersen, Shamik Mitra, Frida Rosengren, Maryem Salim, Johan Vallon-Christersson, Therese Törngren, Anders Kvist, Markus Ringnér, Inge Marie Svane, Göran Jönsson

5 Citations (Scopus)

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Original language	English
Article number	1714
Journal	Nature Communications
Volume	11
Issue number	1
Pages (from-to)	1714
ISSN	2041-1722
DOIs	https://doi.org/10.1038/s41467-020-15531-2
Publication status	Published - 1 Dec 2020

Access to Document

10.1038/s41467-020-15531-2

Cite this

Lauss, M., Donia, M., Harbst, K., Andersen, R., Mitra, S., Rosengren, F., Salim, M., Vallon-Christersson, J., Törngren, T., Kvist, A., Ringnér, M., Svane, I. M., & Jönsson, G. (2020). Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nature Communications, 11(1), 1714. Article 1714. https://doi.org/10.1038/s41467-020-15531-2

Lauss, M, Donia, M, Harbst, K, Andersen, R, Mitra, S, Rosengren, F, Salim, M, Vallon-Christersson, J, Törngren, T, Kvist, A, Ringnér, M, Svane, IM & Jönsson, G 2020, 'Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma', Nature Communications, vol. 11, no. 1, 1714, pp. 1714. https://doi.org/10.1038/s41467-020-15531-2

@article{1d1a5588c8564eeab8c4bc40b7789dc4,

title = "Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma",

abstract = "An amendment to this paper has been published and can be accessed via a link at the top of the paper.",

author = "Martin Lauss and Marco Donia and Katja Harbst and Rikke Andersen and Shamik Mitra and Frida Rosengren and Maryem Salim and Johan Vallon-Christersson and Therese T{\"o}rngren and Anders Kvist and Markus Ringn{\'e}r and Svane, {Inge Marie} and G{\"o}ran J{\"o}nsson",

year = "2020",

month = dec,

day = "1",

doi = "10.1038/s41467-020-15531-2",

language = "English",

volume = "11",

pages = "1714",

journal = "Nature Communications",

issn = "2041-1722",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Author Correction

T2 - Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

AU - Lauss, Martin

AU - Donia, Marco

AU - Harbst, Katja

AU - Andersen, Rikke

AU - Mitra, Shamik

AU - Rosengren, Frida

AU - Salim, Maryem

AU - Vallon-Christersson, Johan

AU - Törngren, Therese

AU - Kvist, Anders

AU - Ringnér, Markus

AU - Svane, Inge Marie

AU - Jönsson, Göran

PY - 2020/12/1

Y1 - 2020/12/1

N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

AB - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

UR - http://www.scopus.com/inward/record.url?scp=85082791176&partnerID=8YFLogxK

U2 - 10.1038/s41467-020-15531-2

DO - 10.1038/s41467-020-15531-2

M3 - Comment/debate

C2 - 32238805

SN - 2041-1722

VL - 11

SP - 1714

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 1714

ER -

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Abstract

Access to Document

Other files and links

Fingerprint

Cite this